Processa Pharmaceuticals, Inc. · NASDAQ:PCSA
Soleus Capital Master Fund, L.P. reported a 5.80% stake in Processa Pharmaceuticals, Inc. (Schedule 13G)
Event Aug 3, 2026 · Filed Aug 18, 2026
Soleus Capital Master Fund, L.P. reported a 5.80% stake in Processa Pharmaceuticals, Inc., 160,943 shares, as a passive investor on Aug 3, 2026. Filed Aug 18, 2026 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 160,943
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Soleus Capital Master Fund, L.P. | 5.80% | 160,943 |
| Soleus Capital, LLC | 5.80% | 160,943 |
| Soleus Capital Group, LLC | 5.80% | 160,943 |
| Soleus Capital Management, L.P. | 5.80% | 160,943 |
| Soleus GP, LLC | 5.80% | 160,943 |
| Guy Levy | 5.80% | 160,943 |